Malignant peripheral nerve sheath tumours in neurofibromatosis 1
St Mary's Hospital · St. Mary's Hospital · +1 more institution
Indexed incrossrefpubmed
Abstract
Background
Cross sectional studies have shown that 1-2% of patients with neurofibromatosis 1 (NF1) develop malignant peripheral nerve sheath tumours (MPNST). However, no population based longitudinal studies have assessed lifetime risk.
Methods
NF1 patients with MPNST were ascertained from two sources for our north west England population of 4.1 million in the 13 year period 1984-1996: the North West Regional NF1 Register and review of notes of patients with MPNST in the North West Regional Cancer Registry.
Citation impact
1,269
total citations
- FWCI
- 11.64
- Percentile
- 100%
- References
- 25
Citations per year
Authors
6- DGD. Gareth EvansCorresponding
St Mary's Hospital, St. Mary's Hospital
- MEM E Baser
- JMJ McGaughran
St Mary's Hospital
- SSS Sharif
St Mary's Hospital
- EHE Howard
St Mary's Hospital
Topics & keywords
Topics
Keywords
- Neurofibromatosis
- Medicine
- Malignant peripheral nerve sheath tumor
- Cancer registry
- Radiation therapy
- Population
- Incidence (geometry)
- Cancer
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.